New insights into uranium’s tricky chemistry

Probing the depths of complex electron shells

09-Sep-2024 - The heavy metal uranium is, besides its radioactive reputation, known for its intricate chemistry and diverse bonding behaviors. Now, an international team of scientists utilized synchrotron light at the Rossendorf Beamline (ROBL) to explore the unique properties of low-valent uranium compounds, ...

Potential approach to how radioactive elements could be 'fished out' of nuclear waste

14-Mar-2017 - Manchester scientists have revealed how arsenic molecules might be used to 'fish out' the most toxic elements from radioactive nuclear waste - a breakthrough that could make the decommissioning industry even safer and more effective. Elizabeth Wildman, a PhD student in the research group led by ...

Improving nuclear waste recycling technologies

27-Dec-2016 - Researchers from The University of Manchester have taken a major step forward by describing the quantitative modelling of the electronic structure of a family of uranium nitride compounds - a process that could in the future help with nuclear waste recycling technologies. "In this nuclear age, ...

How to measure oxygen coefficient in complex oxides

12-Oct-2016 - Scientists of the Faculty of Chemistry of the Lomonosov Moscow State University under the leadership of Prof. Yury Teterin and in cooperation with Russian and British colleagues have developed a technique, which provides an opportunity of quantitative evaluation of oxygen coefficient of uranium ...

Tagging-detagging for purification of radiotracers

10-Jun-2008 - Veronique Gouverneur and colleagues from the University of Oxford and AstraZeneca, Cheshire, have developed a novel tagging-detagging strategy. This could be extremely useful for the purification of known and novel 18F-radiotracers for Positron Emission Tomography. It is the first detagging ...

Dow and Avidex Agree to Develop Biotargeted Radiopharmaceuticals based on mTCR Technology

03-Sep-2003 - Avidex Limited and The Dow Chemical Company will collaborate to create biotargeted radiopharmaceuticals for cancer treatment by applying Dow's technology to Avidex's monoclonal T cell receptors (mTCRs), the companies announced. Under the agreement, proprietary chelation technology and other ...